Barriers and Facilitators to HIV Treatment Adherence in Indonesia: Perspectives of People Living with HIV and HIV Service Providers.
Bona S H HutahaeanSarah E StutterheimKai J JonasPublished in: Tropical medicine and infectious disease (2023)
HIV treatment adherence in Indonesia is a major challenge. Although previous studies have demonstrated several barriers and facilitators to adherence, studies providing a comprehensive analysis from both PLHIV and HIV service providers' perspectives are limited, especially in Indonesia. In this qualitative study with 30 people living with HIV on treatment (PLHIV-OT) and 20 HIV service providers (HSPs), we explored, via online interviews, the barriers and facilitators to antiretroviral therapy (ART) adherence using a socioecological approach. Both PLHIV-OT and HSPs reported stigma as a major barrier at each socioecological level, including public stigma at the societal level, stigma in healthcare settings, and self-stigma at the intrapersonal level. Stigma reduction must therefore be prioritized. PLHIV-OT and HSPs also reported support from significant others and HSPs as the foremost facilitators to ART adherence. The enablement of support networks is thus an important key to improved ART adherence. Overall, the societal level and health system barriers to ART adherence should be addressed in order to remove barriers and enhance the facilitators at the subordinate socioecological levels.
Keyphrases
- antiretroviral therapy
- hiv aids
- hiv infected
- hiv positive
- mental health
- human immunodeficiency virus
- healthcare
- hiv infected patients
- mental illness
- hiv testing
- social support
- heat shock
- men who have sex with men
- hepatitis c virus
- type diabetes
- glycemic control
- emergency department
- social media
- insulin resistance
- south africa
- metabolic syndrome
- health information
- case control
- oxidative stress
- adipose tissue
- adverse drug